Business
SINGZYME WINS 2025 AMGEN X NSG GOLDEN TICKET FOR BREAKTHROUGH BIOCONJUGATION PLATFORM
Singzyme, a Singapore-based biotech startup pioneering next-generation bioconjugation solutions, has been named the winner of the 2025 Golden Ticket Programme in Singapore. The award is part of a joint programme by Amgen, a U.S.-based leader in biologic medicines and NSG BioLabs, Singapore's leading provider of biotechnology co-working laboratories and offices.
About this update from Amgen Inc.
[{"type":"text","content":"Now in its fourth year, the programme continues to empower biotech startups through ecosystem support and collaboration to advance science that serves patients.","length":165,"tagName":"p","attribs":{}},{"type":"text","content":"SINGAPORE, Aug. 21, 2025 /PRNewswire/ -- Singzyme, a Singapore-based biotech startup pioneering next-generation bioconjugation solutions, has been named the winner of the 2025 Golden Ticket Programme in Singapore. The award is part of a joint programme by Amgen, a U.S.-based leader in biologic medicines and NSG BioLabs, Singapore's leading provider of biotechnology co-working laboratories and offices.","length":413,"tagName":"p"},{"type":"image","alt":"Singzyme wins 2025 Amgen x NSG BioLabs Golden Ticket","displaySize":"","headline":null,"caption":"Singzyme wins 2025 Amgen x NSG BioLabs Golden Ticket","className":"","disableSlideshowImg":false,"size":{"original":{"width":1280,"height":720,"url":"https://mma.prnewswire.com/media/2755286/2025_Golden_Ticket_Award_Ceremony.jpg"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1tJa9gg1D4OvlqKLmXu8dw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MDtjZj13ZWJw/https://mma.prnewswire.com/media/2755286/2025_Golden_Ticket_Award_Ceremony.jpg","width":960,"height":540},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/eQU5._lFZS6iLrGxwNnK4A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0xMzUwO2NmPXdlYnA-/https://mma.prnewswire.com/media/2755286/2025_Golden_Ticket_Award_Ceremony.jpg","width":1200,"height":675}},"href":"https://mma.prnewswire.com/media/2755286/2025_Golden_Ticket_Award_Ceremony.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Now in its fourth year, the Golden Ticket Programme supports promising biotech startups by providing infrastructure, mentorship, and resources to advance scientific progress and talent development in accelerating the development of new therapies. As this year's awardee, Singzyme will receive a one-year residency at NSG BioLabs, along with access to certified BSL-2 lab facilities and networking opportunities through Amgen's community of scientific and business leaders.","length":480,"tagName":"p"},{"type":"text","content":"Singzyme was selected from a competitive pool of six finalists following an interactive pitch session reviewed by Amgen's internal scientific committee. The startup stood out fo...